Literature DB >> 22042786

Hot flashes: a review of pathophysiology and treatment modalities.

Phuong Khanh H Morrow1, Danielle N Mattair, Gabriel N Hortobagyi.   

Abstract

Many therapies are being studied for the treatment of hot flashes for individuals with cancer, yet few studies have demonstrated safe and effective clinical benefit for those who suffer from this distressing symptom. The purpose of this paper is to assess the current options for the management of hot flashes, examining key endpoints from recent clinical trials and reviewing future directions. Hot flashes are a common stressful symptom for individuals with cancer, particularly women with a history of breast cancer and men with prostate cancer. Lifestyle modifications are proposed as the first step in the management of less severe hot flashes. Several publications have addressed nonhormonal agents as a treatment option for hot flashes. Newer antidepressant and anticonvulsant agents have been studied and show potential in treating vasomotor symptoms. Although many complementary and alternative therapies, including herbal medications and phytoestrogens, have been studied for the treatment of hot flashes, none are clinically recommended at this time. Additionally, further evidence is needed for supportive exercise such as yoga and relaxation techniques. Acupuncture may warrant further investigation in the reduction and severity of hot flashes in both men and women. Hormonal therapies, including estrogens and progestogens, are the most well-known and efficient agents in alleviating hot flashes; however, the safety of these agents is disputable.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22042786      PMCID: PMC3233302          DOI: 10.1634/theoncologist.2011-0174

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  70 in total

1.  Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomised to physical activity or estrogen therapy.

Authors:  Lotta Lindh-Astrand; Elizabeth Nedstrand; Yvonne Wyon; Mats Hammar
Journal:  Maturitas       Date:  2004-06-15       Impact factor: 4.342

2.  Hot flashes: behavioral treatments, mechanisms, and relation to sleep.

Authors:  Robert R Freedman
Journal:  Am J Med       Date:  2005-12-19       Impact factor: 4.965

3.  Menopausal flushing: double-blind trial of a non-hormonal medication.

Authors:  J R Clayden; J W Bell; P Pollard
Journal:  Br Med J       Date:  1974-03-09

4.  Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss.

Authors:  H B Leonetti; S Longo; J N Anasti
Journal:  Obstet Gynecol       Date:  1999-08       Impact factor: 7.661

5.  Risk of menopause during the first year after breast cancer diagnosis.

Authors:  P J Goodwin; M Ennis; K I Pritchard; M Trudeau; N Hood
Journal:  J Clin Oncol       Date:  1999-08       Impact factor: 44.544

6.  Applied relaxation and oral estradiol treatment of vasomotor symptoms in postmenopausal women.

Authors:  Elizabeth Nedstrand; Klaas Wijma; Yvonne Wyon; Mats Hammar
Journal:  Maturitas       Date:  2005-06-16       Impact factor: 4.342

7.  Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study.

Authors:  G Bertelli; M Venturini; L Del Mastro; M Bergaglio; P Sismondi; N Biglia; S Venturini; G Porcile; P Pronzato; M Costantini; R Rosso
Journal:  Ann Oncol       Date:  2002-06       Impact factor: 32.976

8.  Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study.

Authors:  Catherine M Kelly; David N Juurlink; Tara Gomes; Minh Duong-Hua; Kathleen I Pritchard; Peter C Austin; Lawrence F Paszat
Journal:  BMJ       Date:  2010-02-08

9.  Treating the climacteric symptoms in Indian women with an integrated approach to yoga therapy: a randomized control study.

Authors:  Ritu Chattha; Nagarathna Raghuram; Padmalatha Venkatram; Nagendra R Hongasandra
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

View more
  19 in total

Review 1.  Psychopharmacology in psycho-oncology.

Authors:  Rosangela Caruso; Luigi Grassi; Maria Giulia Nanni; Michelle Riba
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

Review 2.  Dermatological adverse events with taxane chemotherapy.

Authors:  Vincent Sibaud; Nicole R Lebœuf; Henri Roche; Viswanath R Belum; Laurence Gladieff; Marion Deslandres; Marion Montastruc; Audrey Eche; Emmanuelle Vigarios; Florence Dalenc; Mario E Lacouture
Journal:  Eur J Dermatol       Date:  2016-10-01       Impact factor: 3.328

3.  The importance of supportive care in optimizing treatment outcomes of patients with advanced prostate cancer.

Authors:  Florian Scotté
Journal:  Oncologist       Date:  2012

4.  Hot flashes severity, complementary and alternative medicine use, and self-rated health in women with breast cancer.

Authors:  Kavita D Chandwani; Charles E Heckler; Supriya G Mohile; Karen M Mustian; Michelle Janelsins; Luke J Peppone; Peter Bushunow; Patrick J Flynn; Gary R Morrow
Journal:  Explore (NY)       Date:  2014-04-18       Impact factor: 1.775

5.  Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women.

Authors:  David R Walega; Leah H Rubin; Suzanne Banuvar; Lee P Shulman; Pauline M Maki
Journal:  Menopause       Date:  2014-08       Impact factor: 2.953

6.  A randomised trial of the cool pad pillow topper versus standard care for sleep disturbance and hot flushes in women on endocrine therapy for breast cancer.

Authors:  R Marshall-McKenna; A Morrison; L Stirling; C Hutchison; A M Rice; C Hewitt; L Paul; M Rodger; I R Macpherson; E McCartney
Journal:  Support Care Cancer       Date:  2015-10-08       Impact factor: 3.603

Review 7.  Is calcitonin gene-related peptide a modulator of menopausal vasomotor symptoms?

Authors:  Maria Alice Oliveira; William Gustavo Lima; Dante Alighieri Schettini; Cristiane Queixa Tilelli; Valéria Ernestânia Chaves
Journal:  Endocrine       Date:  2018-10-10       Impact factor: 3.633

8.  The Effect of Soy Isoflavones on the Menopause Rating Scale Scoring in Perimenopausal and Postmenopausal Women: A Pilot Study.

Authors:  Marya Ahsan; Ayaz Khurram Mallick
Journal:  J Clin Diagn Res       Date:  2017-09-01

9.  Adverse effects of androgen deprivation therapy for prostate cancer: prevention and management.

Authors:  Petros Sountoulides; Thomas Rountos
Journal:  ISRN Urol       Date:  2013-07-25

10.  Knowledge, attitudes and practices towards menopause among Congolese middle-aged and postmenopausal women.

Authors:  Sifa Marie Joelle Muchanga; Anyeke Louise Lumumba; Bebele Jean Patrice Kamba; Etongola Papy Mbelambela; Antonio Fredelindo Villanueva; Marlinang Diarta Siburian; Rahma Rashid Tozin
Journal:  Pan Afr Med J       Date:  2021-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.